As a gene editing company, GeneLancet Biosciences owns a novel single molecule guide RNA (LgRNA) of distinct intellectual property and develops STAR Editors (novel RGENs) for biological and therapeutic applications.
Our Management Team is composed of experts with gene editing research and industry experiences.
Ms. Sheri Lin
Founder/COO
24 years of operational experience in fortune 500 and early stage companies
Dr.Minghong Zhong
Founder/CEO
Inventor of LgRNA technology
25 years of drug discovery in biopharmaceutical companies
Adjunct professor of translational medicine, Baruch S. Blumberg Institute
Dr. Scott Strobel
Scientific Advisor
Professor of Biochemistry & Biophysics, Chemistry, Yale University
Yale University Provost
Leading expertise in RNA chemistry and biology
Dr. Leonid Beigelman
Scientific Advisor
Top executive in major biopharmaceutical companies
Leading expertise in Discovery and Development of Nucleic Acid Therapeutics and Small Molecules Antivirals
Dr. Ju-Tao Guo, M.D.:
Scientific Advisor
SVP and CSO of Baruch S. Blumberg Institute
Extensive research experience and leading expertise in HBV Biology and drug discovery
